Further, increased activity was found in pathways such as INSR - PI3K - PIP3 - AKT1 and JAK1 - STAT3 in MS patients, while BDNF - NTRK1 - GRB2 was found to be activated in healthy donors. This evidence concerns the gene AKT1 and myeloid sarcoma.